{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:38:53Z","timestamp":1794868733443,"version":"4.9.1"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.addr.2023.114949","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T19:12:15Z","timestamp":1685992335000},"page":"114949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Intrathecal delivery of Macromolecules: Clinical status and emerging technologies"],"prefix":"10.1016","volume":"199","author":[{"given":"Rana","family":"Ajeeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-3041","authenticated-orcid":false,"given":"John R.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2023.114949_b0005","unstructured":"Global Markets and Manufacturing Technologies for Protein Drugs. 2021, BCC Research.: BCCResearch.com."},{"key":"10.1016\/j.addr.2023.114949_b0010","doi-asserted-by":"crossref","unstructured":"Atyabi, F., et al., Chapter 21 - Combination therapy of macromolecules and small molecules: approaches, advantages, and limitations, in Nanostructures for Cancer Therapy, A. Ficai and A.M. Grumezescu, Editors. 2017, Elsevier. p. 541-561.","DOI":"10.1016\/B978-0-323-46144-3.00021-0"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-021-00004-4","article-title":"Insulin at 100: still central in protein-based therapy for chronic disease","volume":"1","author":"Kurtzhals","year":"2021","journal-title":"Communications Medicine"},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal Antibodies in Cancer Therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies"},{"issue":"8","key":"10.1016\/j.addr.2023.114949_b0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/hum.2015.070","article-title":"Oligonucleotide Therapies: The Past and the Present","volume":"26","author":"Lundin","year":"2015","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2023.114949_b0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114949_b0040","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","author":"Lu","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114949_b0045","unstructured":"Route of administration. 2017 [cited 2022 January 13]; Available from: https:\/\/www.fda.gov\/drugs\/data-standards-manual-monographs\/route-administration."},{"issue":"6","key":"10.1016\/j.addr.2023.114949_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061283","article-title":"A Historical Review of Brain Drug Delivery","volume":"14","author":"Pardridge","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40272-018-0298-9","article-title":"The Use of Ommaya Reservoirs to Deliver Central Nervous System-Directed Chemotherapy in Childhood Acute Lymphoblastic Leukaemia","volume":"20","author":"Wilson","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0060","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1213\/ANE.0000000000002011","article-title":"Computational and In Vitro Experimental Investigation of Intrathecal Drug Distribution: Parametric Study of the Effect of Injection Volume, Cerebrospinal Fluid Pulsatility, and Drug Uptake","volume":"124","author":"Tangen","year":"2017","journal-title":"Anesth. Analg."},{"issue":"12","key":"10.1016\/j.addr.2023.114949_b0065","doi-asserted-by":"crossref","first-page":"2102600","DOI":"10.1002\/adhm.202102600","article-title":"Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins","volume":"11","author":"Tian","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"10.1016\/j.addr.2023.114949_b0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis"},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainresrev.2010.04.006","article-title":"The formation of cerebrospinal fluid: Nearly a hundred years of interpretations and misinterpretations","volume":"64","author":"Ore\u0161kovi\u0107","year":"2010","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-8118-11-10","article-title":"A new look at cerebrospinal fluid circulation","volume":"11","author":"Brinker","year":"2014","journal-title":"Fluids and Barriers of the CNS"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0085","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1152\/ajpregu.1992.262.1.R20","article-title":"Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging","volume":"262","author":"Nilsson","year":"1992","journal-title":"Am. J. Physiol. Regulatory, Integr. Compar. Physiol."},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jmri.25591","article-title":"Quantifying the influence of respiration and cardiac pulsations on cerebrospinal fluid dynamics using real-time phase-contrast MRI","volume":"46","author":"Yildiz","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"issue":"7","key":"10.1016\/j.addr.2023.114949_b0095","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1523\/JNEUROSCI.3744-09.2010","article-title":"Cilia Organize Ependymal Planar Polarity","volume":"30","author":"Mirzadeh","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/028418519303400403","article-title":"On the pulsatile nature of intracranial and spinal CSF-circulation demonstrated by MR imaging","volume":"34","author":"Greitz","year":"1993","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06361-x","article-title":"Deep breathing couples CSF and venous flow dynamics","volume":"12","author":"Kollmeier","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114949_b0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2019.06.032","article-title":"The Movement of Cerebrospinal Fluid and Its Relationship with Substances Behavior in Cerebrospinal and Interstitial Fluid","volume":"414","author":"Klarica","year":"2019","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.addr.2023.114949_b0115","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The Glymphatic System: A Beginner\u2019s Guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07318-3","article-title":"Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension","volume":"9","author":"Mestre","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","article-title":"Perivascular spaces in the brain: anatomy, physiology and pathology","volume":"16","author":"Wardlaw","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0130","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41598-019-40128-1","article-title":"Tissue-specific extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array","volume":"9","author":"Lam","year":"2019","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.addr.2023.114949_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313160","article-title":"Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma","volume":"22","author":"Pena","year":"2021","journal-title":"Int. J .Mol. Sci."},{"key":"10.1016\/j.addr.2023.114949_b0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addr.2021.03.002","article-title":"Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues","volume":"173","author":"Naseri Kouzehgarani","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114949_b0145","doi-asserted-by":"crossref","unstructured":"Iliff, J.J., et al., A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid \u03b2. Science Translational Medicine, 2012. 4(147): p. 147ra111-147ra111.","DOI":"10.1126\/scitranslmed.3003748"},{"issue":"6","key":"10.1016\/j.addr.2023.114949_b0150","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00018-020-03706-5","article-title":"Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics","volume":"78","author":"Proulx","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.addr.2023.114949_b0155","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J. Exp. Med."},{"issue":"7560","key":"10.1016\/j.addr.2023.114949_b0160","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuron.2018.09.022","article-title":"The Meningeal Lymphatic System: A New Player in Neurophysiology","volume":"100","author":"Da Mesquita","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0170","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41467-017-01484-6","article-title":"Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice","volume":"8","author":"Ma","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0175","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cpt.2531","article-title":"Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid","volume":"111","author":"Sadekar","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2023.114949_b0180","unstructured":"Drug Delivery An Integrated Clinical and Engineering Approach, ed. Y.R.P.G.N.M. Elman. 2017."},{"issue":"7","key":"10.1016\/j.addr.2023.114949_b0185","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"12","key":"10.1016\/j.addr.2023.114949_b0190","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0195","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/mp300474m","article-title":"Physiology of the Intrathecal Bolus: The Leptomeningeal Route for Macromolecule and Particle Delivery to CNS","volume":"10","author":"Papisov","year":"2013","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0200","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1007\/s12035-017-0501-y","article-title":"Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?","volume":"55","author":"Casaca-Carreira","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids and Barriers of the CNS"},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0210","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000542-199210000-00020","article-title":"Physical and Chemical Properties of Drug Molecules Governing their Diffusion Through the Spinal Meninges","volume":"77","author":"Bernards","year":"1992","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.addr.2023.114949_b0215","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/00000542-199012000-00020","article-title":"Morphine and Alfentanil Permeability Through the Spinal Dura, Arachnoid, and Pia Mater of Dogs and Monkeys","volume":"73","author":"Bernards","year":"1990","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0220","article-title":"Periarteriolar spaces modulate cerebrospinal fluid transport into brain and demonstrate altered morphology in aging and Alzheimer\u2019s disease. Nature","volume":"13","author":"Mestre","year":"2022","journal-title":"Communications"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66042-5","article-title":"Apparent diffusion coefficient estimates based on 24 hours tracer movement support glymphatic transport in human cerebral cortex","volume":"10","author":"Valnes","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13346-012-0073-3","article-title":"Delivery of proteins to CNS as seen and measured by positron emission tomography","volume":"2","author":"Papisov","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2023.114949_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00511","article-title":"The Configuration of the Perivascular System Transporting Macromolecules in the CNS","volume":"13","author":"Durcanova","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0240","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-022-00304-4","article-title":"Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology","volume":"19","author":"Khani","year":"2022","journal-title":"Fluids and Barriers of the CNS"},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0245","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","article-title":"Diffusion in Brain Extracellular Space","volume":"88","author":"Sykov\u00e1","year":"2008","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0250","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-019-0126-9","article-title":"Analysis of convective and diffusive transport in the brain interstitium","volume":"16","author":"Ray","year":"2019","journal-title":"Fluids and Barriers of the CNS"},{"issue":"14","key":"10.1016\/j.addr.2023.114949_b0255","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0509425103","article-title":"In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space","volume":"103","author":"Thorne","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0260","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp300495e","article-title":"Diffusion of Macromolecules in the Brain: Implications for Drug Delivery","volume":"10","author":"Wolak","year":"2013","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.addr.2023.114949_b0265","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On The Rate and Extent of Drug Delivery to the Brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0270","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-019-0133-x","article-title":"The need for mathematical modelling of spatial drug distribution within the brain","volume":"16","author":"Vendel","year":"2019","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.addr.2023.114949_b0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pharmthera.2017.10.008","article-title":"CYP-mediated drug metabolism in the brain impacts drug response","volume":"184","author":"McMillan","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2020.1858856","article-title":"Cytochrome P450 expression and regulation in the brain","volume":"53","author":"Kuban","year":"2021","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0285","article-title":"Targeted protein degradation: mechanisms, strategies and application. Signal Transduction and Targeted","volume":"7","author":"Zhao","year":"2022","journal-title":"Therapy"},{"key":"10.1016\/j.addr.2023.114949_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101088","article-title":"The potential roles of deubiquitinating enzymes in brain diseases","volume":"61","author":"Lim","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.addr.2023.114949_b0295","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem Biol"},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0300","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12291-012-0273-0","article-title":"Activity of Hydrolytic Enzymes in Various Regions of Normal Human Brain Tissue","volume":"28","author":"Prabha","year":"2013","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.addr.2023.114949_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2021.665803","article-title":"Waste Clearance in the Brain","volume":"15","author":"Kaur","year":"2021","journal-title":"Front. Neuroanat."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-018-0113-6","article-title":"Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood\u2013brain barrier","volume":"15","author":"Hladky","year":"2018","journal-title":"Fluids and Barriers of the CNS"},{"issue":"9","key":"10.1016\/j.addr.2023.114949_b0315","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/pharmaceutics14091764","article-title":"Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model","volume":"14","author":"Hirasawa","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.114949_b0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2015.07.027","article-title":"A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans","volume":"273","author":"Spector","year":"2015","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/diagnostics12010079","article-title":"Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities","volume":"12","author":"Otto","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2045-8118-11-26","article-title":"Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence","volume":"11","author":"Hladky","year":"2014","journal-title":"Fluids and Barriers of the CNS"},{"issue":"6","key":"10.1016\/j.addr.2023.114949_b0335","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41565-021-00924-1","article-title":"Environmental dimensions of the protein corona","volume":"16","author":"Wheeler","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0340","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573403X10666140914160554","article-title":"Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases","volume":"10","author":"Song","year":"2014","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.addr.2023.114949_b0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2020.03.009","article-title":"Clearance of two organic nanoparticles from the brain via the paravascular pathway","volume":"322","author":"Gu","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfw072","article-title":"Safety Evaluation of CNS Administered Biologics\u2014Study Design, Data Interpretation, and Translation to the Clinic","volume":"152","author":"Vuillemenot","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.addr.2023.114949_b0355","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/JPR.S37591","article-title":"Current perspectives on intrathecal drug delivery","author":"Christo","year":"2014","journal-title":"J. Pain Res."},{"key":"10.1016\/j.addr.2023.114949_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114338","article-title":"Intrathecal delivery and its applications in leptomeningeal disease","volume":"186","author":"Khang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114949_b0365","unstructured":"ClinicalTrials.gov. 2022."},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/17425240903540205","article-title":"Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics","volume":"7","author":"Soderquist","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2023.114949_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5533886","article-title":"Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain","volume":"2021","author":"Kashaju","year":"2021","journal-title":"Comput. Math. Methods Med."},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0380","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13311-017-0520-4","article-title":"Convection-Enhanced Delivery","volume":"14","author":"Mehta","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.addr.2023.114949_b0385","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jconrel.2022.06.067","article-title":"Noninvasive ultrasonic induction of cerebrospinal fluid flow enhances intrathecal drug delivery","volume":"349","author":"Aryal","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0390","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17314-9","article-title":"Enhancement of cerebrospinal fluid tracer movement by the application of pulsed transcranial focused ultrasound","volume":"12","author":"Yoo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114949_b0395","doi-asserted-by":"crossref","unstructured":"De Andr\u00e9s, J., et al., Intrathecal Drug Delivery, in Drug Delivery Systems, K.K. Jain, Editor. 2020, Springer New York: New York, NY. p. 75-108.","DOI":"10.1007\/978-1-4939-9798-5_3"},{"issue":"7","key":"10.1016\/j.addr.2023.114949_b0400","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/ner.12693","article-title":"Intrathecal Therapeutics: Device Design, Access Methods, and Complication Mitigation","volume":"21","author":"Nagel","year":"2018","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0405","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1159\/000519831","article-title":"Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal Deformity","volume":"13","author":"Papaliagkas","year":"2021","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.addr.2023.114949_b0410","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2021.04.006","article-title":"Particle engineering principles and technologies for pharmaceutical biologics","volume":"174","author":"Cun","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114949_b0415","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2020.02.006","article-title":"Intrathecal drug delivery in the era of nanomedicine","volume":"165\u2013166","author":"Fowler","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.addr.2023.114949_b0420","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-021-00611-y","article-title":"FDA\u2019s Poly (Lactic-Co-Glycolic Acid) Research Program and Regulatory Outcomes","volume":"23","author":"Wang","year":"2021","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0425","first-page":"233","article-title":"Changes in compressed neurons from dogs with acute and severe cauda equina constrictions following intrathecal injection of brain-derived neurotrophic factor-conjugated polymer nanoparticles","volume":"8","author":"Tan","year":"2013","journal-title":"Neural Regen Res"},{"issue":"11","key":"10.1016\/j.addr.2023.114949_b0430","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.3390\/ijms22115657","article-title":"IKBKB siRNA-Encapsulated Poly (Lactic-co-Glycolic Acid) Nanoparticles Diminish Neuropathic Pain by Inhibiting Microglial Activation","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.addr.2023.114949_b0435","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/ijms21103469","article-title":"CX3CR1-Targeted PLGA Nanoparticles Reduce Microglia Activation and Pain Behavior in Rats with Spinal Nerve Ligation","volume":"21","author":"Noh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0440","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12975-020-00874-1","article-title":"Protective Effects of ShcA Protein Silencing for Photothrombotic Cerebral Infarction","volume":"12","author":"Hwang","year":"2021","journal-title":"Transl Stroke Res"},{"issue":"11","key":"10.1016\/j.addr.2023.114949_b0445","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2217\/nnm-2019-0462","article-title":"miRNA 146a\u20135p-loaded poly(d, l-lactic-co-glycolic acid) nanoparticles impair pain behaviors by inhibiting multiple inflammatory pathways in microglia","volume":"15","author":"Ph\u1ea1m","year":"2020","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.addr.2023.114949_b0450","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nano.2019.02.023","article-title":"Foxp3 plasmid-encapsulated PLGA nanoparticles attenuate pain behavior in rats with spinal nerve ligation","volume":"18","author":"Shin","year":"2019","journal-title":"Nanomedicine"},{"issue":"13","key":"10.1016\/j.addr.2023.114949_b0455","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2217\/nnm-2018-0054","article-title":"p38 siRNA-encapsulated PLGA nanoparticles alleviate neuropathic pain behavior in rats by inhibiting microglia activation","volume":"13","author":"Shin","year":"2018","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0460","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11095-010-0077-y","article-title":"Release of Plasmid DNA-Encoding IL-10 from PLGA Microparticles Facilitates Long-Term Reversal of Neuropathic Pain Following a Single Intrathecal Administration","volume":"27","author":"Soderquist","year":"2010","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0465","doi-asserted-by":"crossref","first-page":"20019","DOI":"10.1038\/srep20019","article-title":"Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich\u2019s ataxia","volume":"6","author":"Nabhan","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0470","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2013.03.009","article-title":"Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord","volume":"168","author":"Dengler","year":"2013","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0475","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/cells9051273","article-title":"Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes","volume":"9","author":"Haney","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.addr.2023.114949_b0480","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/psc.2857","article-title":"Inhibition of the norepinephrine transporter by \u03c7-conotoxin dendrimers","volume":"22","author":"Wan","year":"2016","journal-title":"J. Pept. Sci."},{"issue":"10","key":"10.1016\/j.addr.2023.114949_b0485","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1021\/acs.nanolett.9b02958","article-title":"Aptamer-Conjugated Framework Nucleic Acids for the Repair of Cerebral Ischemia-Reperfusion Injury","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2023.114949_b0490","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG - a versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2023.114949_b0495","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000339589","article-title":"Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury","volume":"197","author":"Kang","year":"2013","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/C4BM00311J","article-title":"Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord","volume":"3","author":"Elliott Donaghue","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2023.114949_b0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.04.016","article-title":"Local delivery of chondroitinase ABC with or without stromal cell-derived factor 1\u03b1 promotes functional repair in the injured rat spinal cord","volume":"134","author":"Pakulska","year":"2017","journal-title":"Biomaterials"},{"issue":"26","key":"10.1016\/j.addr.2023.114949_b0515","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1523\/JNEUROSCI.3084-17.2018","article-title":"Local BDNF Delivery to the Injured Cervical Spinal Cord using an Engineered Hydrogel Enhances Diaphragmatic Respiratory Function","volume":"38","author":"Ghosh","year":"2018","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0520","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/1673-5374.290882","article-title":"Hydrogel-based local drug delivery strategies for spinal cord repair","volume":"16","author":"Shultz","year":"2021","journal-title":"Neural Regen Res"},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0525","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/14712598.2018.1416089","article-title":"AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials","volume":"18","author":"Hardcastle","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"issue":"21","key":"10.1016\/j.addr.2023.114949_b0530","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-18-0363","article-title":"Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice","volume":"78","author":"Rothwell","year":"2018","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.addr.2023.114949_b0535","doi-asserted-by":"crossref","first-page":"e0264938","DOI":"10.1371\/journal.pone.0264938","article-title":"Targeting the somatosensory system with AAV9 and AAV2retro viral vectors","volume":"17","author":"Skorput","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0540","article-title":"Viral Vectors Encoding Endomorphins and Serine Histogranin Attenuate Neuropathic Pain Symptoms after Spinal Cord Injury in Rats","volume":"11","author":"Nasirinezhad","year":"2015","journal-title":"Mol. Pain"},{"issue":"11","key":"10.1016\/j.addr.2023.114949_b0545","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jnr.23882","article-title":"Intrathecal administration of AAV\/GALC vectors in 10\u201311-day-old twitcher mice improves survival and is enhanced by bone marrow transplant","volume":"94","author":"Karumuthil-Melethil","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.addr.2023.114949_b0550","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omtm.2021.09.001","article-title":"Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome","volume":"23","author":"Ling","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.addr.2023.114949_b0555","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1021\/acs.molpharmaceut.1c00252","article-title":"Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection","volume":"18","author":"Pflepsen","year":"2021","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.addr.2023.114949_b0560","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ymthe.2021.07.010","article-title":"A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system","volume":"29","author":"Kondratov","year":"2021","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.addr.2023.114949_b0565","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ymthe.2019.07.017","article-title":"AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice","volume":"27","author":"Liguore","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0570","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02694-1","article-title":"Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery","volume":"11","author":"Kagiava","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114949_b0575","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2017.00245","article-title":"Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord","volume":"8","author":"Ziemba","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.addr.2023.114949_b0580","doi-asserted-by":"crossref","DOI":"10.1088\/1748-6041\/8\/2\/022001","article-title":"Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors","volume":"8","author":"Mohtaram","year":"2013","journal-title":"Biomed. Mater."},{"issue":"10","key":"10.1016\/j.addr.2023.114949_b0585","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/1061186X.2015.1029930","article-title":"Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor","volume":"23","author":"Garg","year":"2015","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.addr.2023.114949_b0590","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.2017.026","article-title":"Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:39:44Z","timestamp":1759210784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X23002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":118,"alternative-id":["S0169409X23002648"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.114949","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal delivery of Macromolecules: Clinical status and emerging technologies","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.114949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114949"}}